Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

December 1, 2019

Study Completion Date

November 1, 2020

Conditions
Alzheimer's DementiaParkinson Disease(PD)Fronto-Temporal Dementia
Interventions
OTHER

No intervention. Only survey and normal use of eye-tracking

"The study is conducted in accordance with usual practices of eye-tracking and neuropsychological evaluations carried out at the Center Rainier III.~Eye-Tracker® is used at the Centre Rainier III since August 2014. It is a non-invasive device for eye movements recording, allowing doctors and researchers to measure standard parameters related to eye movements. Developed by the Eye Brain Company (France), this is a Class IIa medical device, CE marking, according to Annexe IX of the directive 93/42/CE."

All Listed Sponsors
collaborator

Association de Recherche Bibliographique pour les Neurosciences

OTHER

lead

Centre Hospitalier Princesse Grace

OTHER

NCT04748263 - Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study) | Biotech Hunter | Biotech Hunter